Journey Strategic Wealth’s Zosano Pharma Corporation ZSAN Stock Holding History

Journey Strategic Wealth’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-571	Closed	-$5K	–	227
2022 Q1	$5K	Buy	571 +285	+100%	+$3.14K	﹤0.01%	180
2021 Q4	$5K	Buy	+286	New	+$6.04K	﹤0.01%	210

Other funds holding ZSAN

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Journey Strategic Wealth's ZSAN Position: Q2 2022 in Review

Journey Strategic Wealth sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 571 shares — an estimated $5K sold.

Journey Strategic Wealth first reported a position in ZSAN in Q4 2021 and held it in 2 quarters. The position peaked at $5K in Q1 2022. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

Journey Strategic Wealth reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
Journey Strategic Wealth sold 571 Zosano Pharma Corporation shares in Q2 2022, an estimated $5K.
Journey Strategic Wealth first reported a position in Zosano Pharma Corporation in Q4 2021 and held it in 2 quarters.
Journey Strategic Wealth's Zosano Pharma Corporation position peaked at $5K in Q1 2022.
3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Journey Strategic Wealth's 13F filing for Q2 2022, filed 15 Aug 2022.